Cubist Systematic Strategies’s Ascendis Pharma A/S ASND Stock Holding History

Cubist Systematic Strategies’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-33,661	Closed	-$5.09M	–	2959
2024 Q1	$5.09M	Buy	33,661 +14,770	+78%	+$2.11M	0.03%	953
2023 Q4	$2.38M	Buy	+18,891	New	+$1.88M	0.02%	1392
2023 Q1	–	Sell	-9,603	Closed	-$1.17M	–	3883
2022 Q4	$1.17M	Sell	9,603 -2,521	-21%	-$293K	0.01%	2288
2022 Q3	$1.25M	Buy	12,124 +9,526	+367%	+$903K	0.01%	2423
2022 Q2	$242K	Buy	+2,598	New	+$245K	﹤0.01%	3576
2022 Q1	–	Sell	-110	Closed	-$15K	–	3548
2021 Q4	$15K	Sell	110 -28	-20%	-$4.17K	﹤0.01%	3390
2021 Q3	$22K	Sell	138 -508	-79%	-$69.5K	﹤0.01%	2882
2021 Q2	$85K	Buy	646 +355	+122%	+$47.3K	﹤0.01%	2727
2021 Q1	$38K	Sell	291 -590	-67%	-$89.7K	﹤0.01%	2747
2020 Q4	$147K	Buy	+881	New	+$146K	﹤0.01%	2341
2020 Q2	–	Sell	-92	Closed	-$10K	–	2387
2020 Q1	$10K	Buy	+92	New	+$12K	﹤0.01%	2087
2019 Q2	–	Sell	-8,517	Closed	-$1M	–	2439
2019 Q1	$1M	Buy	8,517 +3,995	+88%	+$350K	0.03%	764
2018 Q4	$283K	Buy	+4,522	New	+$284K	0.01%	1322

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cubist Systematic Strategies's ASND Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Ascendis Pharma A/S (ASND) in Q2 2024, closing a stake of 33,661 shares — an estimated $5.09M sold.

Cubist Systematic Strategies first reported a position in ASND in Q4 2018 and held it in 13 quarters. The position peaked at $5.09M in Q1 2024. 203 funds tracked by Wall St. Rank hold ASND as of Q2 2024.

Cubist Systematic Strategies reported no remaining Ascendis Pharma A/S position as of Q2 2024 after selling out during the quarter.
Cubist Systematic Strategies sold 33,661 Ascendis Pharma A/S shares in Q2 2024, an estimated $5.09M.
Cubist Systematic Strategies first reported a position in Ascendis Pharma A/S in Q4 2018 and held it in 13 quarters.
Cubist Systematic Strategies's Ascendis Pharma A/S position peaked at $5.09M in Q1 2024.
203 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.